CLDX Celldex Therapeutics, Inc. logo

CLDX Celldex Therapeutics, Inc.

Healthcare
$30.72+0.00%OpenMarket Cap: $2.04B

As of 2026-05-26

Institutional Ownership Summary

Investors Holding

187

13F Shares

73,398,380

Ownership %

110.5%

New Positions

24

Increased Positions

83

Closed Positions

24

Reduced Positions

60

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
SURISimplify Propel Opportunities ETF68,9943.04%
SBIOALPS Medical Breakthroughs ETF54,1901.34%
XBI1,222,4800.52%
LABUDirexion Daily S&P Biotech Bull 3X ETF61,2040.39%
ANOGX558,9690.31%
VGHAX4,249,6560.29%
VGHCX4,249,6560.29%
AVSCAvantis U.S. Small Cap Equity ETF119,8340.16%
NAJ560,9910.14%
IWNiShares Russell 2000 Value ETF560,9910.14%
VEXPX1,057,5400.14%
VEXRX1,057,5400.14%
TMSLT. Rowe Price Small-Mid Cap ETF66,6680.14%
VTWV48,4240.13%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity ETF20,5400.10%
NJM1,601,4540.07%
IWMiShares Russell 2000 ETF1,601,4540.07%
ESMLiShares ESG Aware MSCI USA Small-Cap ETF49,6170.07%
PRFZInvesco RAFI US 1500 Small-Mid ETF56,0250.07%
VTWO324,5060.06%